Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) |
Stages | Expansion, Later Stage, MBO/LBO |
Investing | United States • United Kingdom • Europe |
Investment Range | $5,000,000 - $20,000,000 |
Assets Under Management | $200,000,000 |
Apposite Capital LLP is a private equity fund specifically focused on the healthcare sector. With a specialty in equity investments, they target companies across various segments such as BioTech, HealthTech & Fitness, Medical Devices & Hospital Services. Their minimum investment size is 5 million, while the maximum can reach up to 20 million. Based in London, Apposite Capital prides itself on having strategic specialties in Expansion, Later Stage ventures, and Management Buyout/Management Buy-In (MBO/LBO) opportunities. They manage assets totaling approximately 200 million. With 18 years of experience, Apposite Capital has been involved in 29 investments and over 40 bolt-on acquisitions, culminating in 16 exits. Their investment approach emphasizes close collaboration with management teams, providing commercial and strategic support along with access to a network of over 100 senior advisors with healthcare experience. Their portfolio caters to companies with up to 100 million in revenue and offers flexible capital solutions for MBOs, Buy-ins, and Minority Growth Capital with a key focus on health impact via high-quality, efficient, and cost-effective care solutions. Their ethos revolves around building market leaders in healthcare, promoting excellence, innovation, and positive impact. They support diversity and equality across their investments and commit a portion of their profits from their latest fund to healthcare charities and good causes. Apposite Capital uses their extensive sectoral knowledge in aiding companies' growth into new markets, product lines, and geographical expansion while also supporting operational improvement through key talents and digital transformation. With a hands-on approach, they partner with investee companies to provide strategic direction, facilitate M&A processes, and leverage their international network to propel growth.